Compare CYRX & PDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYRX | PDT |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 774.7M | 653.2M |
| IPO Year | 2008 | 1994 |
| Metric | CYRX | PDT |
|---|---|---|
| Price | $16.92 | $12.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $13.31 | N/A |
| AVG Volume (30 Days) | ★ 527.4K | 118.5K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 156.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $176,177,000.00 | N/A |
| Revenue This Year | $11.06 | N/A |
| Revenue Next Year | $8.45 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.61 | $12.53 |
| 52 Week High | $16.89 | $13.65 |
| Indicator | CYRX | PDT |
|---|---|---|
| Relative Strength Index (RSI) | 65.07 | 36.50 |
| Support Level | $14.55 | $12.60 |
| Resistance Level | N/A | $13.02 |
| Average True Range (ATR) | 0.62 | 0.15 |
| MACD | 0.19 | -0.01 |
| Stochastic Oscillator | 98.61 | 2.22 |
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
John Hancock Premium Div Fund is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest capital growth. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, capital preferred securities, and short-term investments.